CULVER CITY, Calif.–(BUSINESS WIRE)–This evening at the 78th Primetime Emmy Awards, Apple TV shatters records to become the most awarded network of the year, landing 29 wins overall, including Outstanding Comedy Series for Widow’s Bay as the breakout sensation sweeps all major categories with 14 wins in total and cements itself as the most Emmy-awarded freshman comedy series in history. Additionally, Widow’s Bay lands the most wins for a comedy series in a single season, as well as the most p

CULVER CITY, Calif.–(BUSINESS WIRE)–This evening at the 78th Primetime Emmy Awards, Apple TV shatters records to become the most awarded network of the year, landing 29 wins overall, including Outstanding Comedy Series for Widow’s Bay as the breakout sensation sweeps all major categories with 14 wins in total and cements itself as the most Emmy-awarded freshman comedy series in history. Additionally, Widow’s Bay lands the most wins for a comedy series in a single season, as well as the most p

NEW YORK–(BUSINESS WIRE)– #AI–Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Queen of Hearts (ACS AI ECG Model). The AI-powered model is designed to identify ECG findings suggestive of urgent acute coronary syndrome (ACS), which can include ST-segment elevation myocardial infarction (STEMI) and STEMI equivalents, and urgently notify clinicians of suspected cases. Heart attack

NEW YORK–(BUSINESS WIRE)– #AI–Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Queen of Hearts (ACS AI ECG Model). The AI-powered model is designed to identify ECG findings suggestive of urgent acute coronary syndrome (ACS), which can include ST-segment elevation myocardial infarction (STEMI) and STEMI equivalents, and urgently notify clinicians of suspected cases. Heart attack

LONDON–(BUSINESS WIRE)–    DMO-TAS041/3728/002         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A12226 15 September 2026   PRESS NOTICE   RESULT OF THE SALE BY TENDER OF UP TO £1250 MILLION OF 0½% TREASURY GILT 2029The United Kingdom Debt Management Office (“DMO”) announces that the tender of up to £1,250 million of 0½% Treasury Gilt 2029 (ISIN Code: GB00BLPK7227) has been allocated as follows:(Note: all prices in this notice ar

LONDON–(BUSINESS WIRE)–    DMO-TAS041/3728/002         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A12226 15 September 2026   PRESS NOTICE   RESULT OF THE SALE BY TENDER OF UP TO £1250 MILLION OF 0½% TREASURY GILT 2029The United Kingdom Debt Management Office (“DMO”) announces that the tender of up to £1,250 million of 0½% Treasury Gilt 2029 (ISIN Code: GB00BLPK7227) has been allocated as follows:(Note: all prices in this notice ar

SEOUL, South Korea–(BUSINESS WIRE)–Genexine, Inc. (KOSDAQ: 095700) announced that Jaehyun Choi, Ph.D., CEO and Head of R&D, presented new preclinical data for GX-BP1, the company’s SOX2-targeting bioPROTAC, at the 2026 World Conference on Lung Cancer (WCLC) in Seoul on September 13. The mini oral presentation, titled ‘Lung-Targeted mRNA-LNP Delivery of SOX2 bioPROTAC: A Comprehensive Strategy for LUAD, LUSC, and SCLC in Monotherapy and Combination Settings’ highlighted the potential of GX

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.